Heterocodeine (original) (raw)
From Wikipedia, the free encyclopedia
Chemical compound
Pharmaceutical compound
Heterocodeine
![]() |
|
---|---|
![]() |
|
Clinical data | |
Other names | Heterocodeine, Morphine 6-methyl ether |
ATC code | none |
Legal status | |
Legal status | US: Schedule II |
Identifiers | |
IUPAC name (5α,6α)-6-Methoxy-17-methyl-7,8-didehydro-4,5-epoxymorphinan-3-ol | |
CAS Number | 639-47-4 ![]() |
PubChem CID | 5462505 |
ChemSpider | 4575432 ![]() |
UNII | SBO5K94K8L |
ChEMBL | ChEMBL358043 ![]() |
CompTox Dashboard (EPA) | DTXSID40905126 ![]() |
ECHA InfoCard | 100.010.325 ![]() |
Chemical and physical data | |
Formula | C18H21NO3 |
Molar mass | 299.370 g·mol−1 |
3D model (JSmol) | Interactive image |
SMILES O(C)[C@H]2\C=C/[C@H]5[C@@H]4N(CC[C@@]51c3c(O[C@H]12)c(O)ccc3C4)C | |
InChI InChI=1S/C18H21NO3/c1-19-8-7-18-11-4-6-14(21-2)17(18)22-16-13(20)5-3-10(15(16)18)9-12(11)19/h3-6,11-12,14,17,20H,7-9H2,1-2H3/t11-,12+,14-,17-,18-/m0/s1 ![]() ![]() |
|
![]() ![]() |
Heterocodeine (6-methoxymorphine) is an opiate derivative, the 6-methyl ether of morphine, and a structural isomer of codeine; it is called "hetero-" because it is the reverse isomer of codeine. Heterocodeine was first synthesised in 1932 and first patented in 1935.[1] It can be made from morphine by selective methylation.[2] Codeine is the natural mono-methyl ether, but must be metabolized for activity (that is, it is a prodrug). In contrast the semi-synthetic mono-methyl ether, heterocodeine is a direct agonist. The 6,7,8,14 tetradehydro 3,6 methyl di-ether of morphine is thebaine.
Heterocodeine is 6 times more potent than morphine[3] due to having a substitution at the 6-hydroxy position, in a similar manner to 6-acetylmorphine.[4] The drug methyldihydromorphine (dihydroheterocodeine) is a derivative of heterocodeine. Like the morphine metabolite morphine-6-glucuronide, 6-position branches (esters or ethers) of morphine bind to the otherwise unagonized human mu receptor subtype mu-3 (or μ3); as well as the 6-acetylmorphine metabolite of heroin this includes heterocodeine.[5]
The relative strength of heterocodeine to codeine has been published as 50, 72, 81, 88, 93, 96, and 108 ×.
It is not mentioned specifically in the Controlled Substances Act 1970 but is a Schedule II controlled substance as an analogue of morphinan or morphine under the morphine structure rules of the Analogues Act; in other countries it is usually controlled as a strong opioid.
Homocodeine is a synonym for pholcodine. Bicodeine is a dimer of codeine which is essentially the codeine analogue of pseudomorphine and is also known as pseudocodeine. It is an occasional component of opium and is also a decomposition product of codeine under certain circumstances.[6]
- ^ US 2058521
- ^ Barber RB, Rapoport H (November 1975). "Synthesis of thebaine and oripavine from codeine and morphine". Journal of Medicinal Chemistry. 18 (11): 1074–7. doi:10.1021/jm00245a006. PMID 1177252.
- ^ Woster PM. "Chemistry of Opioid Analgesics". PHA 5155- Neurology Pharmacotherapeutics Medicinal Chemistry Tutorials. Archived from the original on 2007-07-16.
- ^ Coop A, Jacobson AE (2000). "Biological evaluation of compounds for their physical dependence potential & abuse liability. XXIV" (PDF). Drug evaluation committee of the college on problems of drug dependence.
- ^ Brown GP, Yang K, King MA, Rossi GC, Leventhal L, Chang A, Pasternak GW (July 1997). "3-Methoxynaltrexone, a selective heroin/morphine-6beta-glucuronide antagonist". FEBS Letters. 412 (1): 35–8. doi:10.1016/S0014-5793(97)00710-2. PMID 9257684. S2CID 45475657.
- ^ "Status Decision of Controlled and Non-Controlled Substances: Codeine dimer" (PDF). Health Canada. 15 June 2005.